BackTNF Pharmaceuticals Overview

TNF Pharmaceuticals Intangible Assets

Track TNF Pharmaceuticals's intangible assets ($14M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$14.09M

Peer average

Loading

TNF Pharmaceuticals Intangible Assets History

Loading

TNF Pharmaceuticals vs. peers: Intangible Assets Comparison

Loading

TNF Pharmaceuticals Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

TNF Pharmaceuticals (TNFA) FAQ

TNF Pharmaceuticals posts a intangible assets of $14M as of March 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, TNF Pharmaceuticals's intangible assets was $0. The latest reading is $14M (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Intangible Assets is one piece of TNF Pharmaceuticals's financial statement story. At $14M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for TNFA's intangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; TNF Pharmaceuticals's other metric pages and overview cover the third.